
International start-ups receive funding from BioInnovation
Three international life sciences start-ups have received investment from the BioInnovation Institute (BII). The three new ventures were chosen as part of the BII’s focus on developing scientific initiatives across the therapeutics and health tech space. The companies, Sevenless Therapeutics, VEIL.AI and Myopax, will receive €1.3 million and will form… Read More





